References
- Cohen-Cole SA, Brown FW, McDaniel JS. Assessment of depression and grief reactions in the mentally ill. Psychiatric care of the medical patient. New York: Oxford University Press, A Stoudemire, BS Fogel, 1993; 53–69
- Rodin G, Craven J, Littlefield C. Depression in the medically ill. An integrated approach. New York: Brunner/Mazel,. 1991; 299–343
- Frierson RL, Wey JJ, Tabler JB. Psychostimulants for depression in the medically ill. American Family Physician 1991; 43: 163–170
- Hintz S, Kuck J, Peterkin JJ, Volk DM, Zisook S. Depression in the context of human immunodeficiency virus infection: implications for treatment. Journal of Clinical Psychiatry 1990; 51: 497–501
- Rabkin JG, Harrison WM. Effect of imipramine on depression and immune states in a sample of men with HIV infection. American Journal of Psychiatry 1990; 147: 495–497
- Rabkin JG, Rabkin R, Harrison W, Wagner G. Effect of imipramine on mood and enumerative measures of immune status in depressed patients with HIV illness. American Journal of Psychiatry 1994; 151: 516–523
- Lemberger L, Bergstrom RF, Wolen RL. Fluoxetine: clinical pharmacology and physiologic disposition. Journal of Clinical Psychiatry 1985; 46: 14–19
- Levine S, Anderson D, Bystritsky A, Baron D. A report of eight HIV seropositive patients with major depression responding to fluoxetine. Journal of Acquired Immunodeficiency Syndromes 1990; 3: 1074–1077
- Rabkin JG, Rabkin R, Wagner G. Effect of fluoxetine on mood and immune status in depressed patients with HIV illness. Journal of Clinical Psychiatry 1994; 55: 92–97
- Fernandez F, Levy JK. Psychopharmacology of psychiatric symptoms in asymptomatic and symptomatic HIV infection. Psychiatric Medicine 1991; 9: 377–394